258 related articles for article (PubMed ID: 31622604)
41. Forced swimming-induced oxytocin release into blood and brain: Effects of adrenalectomy and corticosterone treatment.
Torner L; Plotsky PM; Neumann ID; de Jong TR
Psychoneuroendocrinology; 2017 Mar; 77():165-174. PubMed ID: 28064086
[TBL] [Abstract][Full Text] [Related]
42. A possible mechanism contributing to the synergistic action of vasotocin (VT) and corticotropin-releasing hormone (CRH) receptors on corticosterone release in birds.
Cornett LE; Kang SW; Kuenzel WJ
Gen Comp Endocrinol; 2013 Jul; 188():46-53. PubMed ID: 23499785
[TBL] [Abstract][Full Text] [Related]
43. Expression of hypothalamic arginine vasotocin gene in response to water deprivation and sex steroid administration in female Japanese quail.
Seth R; Köhler A; Grossmann R; Chaturvedi CM
J Exp Biol; 2004 Aug; 207(Pt 17):3025-33. PubMed ID: 15277557
[TBL] [Abstract][Full Text] [Related]
44. Restraint-induced corticosterone secretion and hypothalamic CRH mRNA expression are augmented during acute withdrawal from chronic cocaine administration.
Mantsch JR; Taves S; Khan T; Katz ES; Sajan T; Tang LC; Cullinan WE; Ziegler DR
Neurosci Lett; 2007 Mar; 415(3):269-73. PubMed ID: 17293045
[TBL] [Abstract][Full Text] [Related]
45. Gestational hypoxia alone or combined with restraint sensitizes the hypothalamic-pituitary-adrenal axis and induces anxiety-like behavior in adult male rat offspring.
Fan JM; Chen XQ; Jin H; Du JZ
Neuroscience; 2009 Apr; 159(4):1363-73. PubMed ID: 19409200
[TBL] [Abstract][Full Text] [Related]
46. Vasopressin V1a, but not V1b, receptors within the PVN of lactating rats mediate maternal care and anxiety-related behaviour.
Bayerl DS; Hönig JN; Bosch OJ
Behav Brain Res; 2016 May; 305():18-22. PubMed ID: 26909846
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice.
Wang L; Hiller H; Smith JA; de Kloet AD; Krause EG
Physiol Genomics; 2016 Sep; 48(9):667-76. PubMed ID: 27468749
[TBL] [Abstract][Full Text] [Related]
48. The inflamed axis: the interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis.
Hueston CM; Deak T
Physiol Behav; 2014 Jan; 124():77-91. PubMed ID: 24184413
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of corticosterone in the hypothalamic paraventricular nucleus (PVN) on stress-induced adrenocorticotrophic hormone secretion and gene expression in the PVN and anterior pituitary.
Weiser MJ; Osterlund C; Spencer RL
J Neuroendocrinol; 2011 Dec; 23(12):1231-40. PubMed ID: 21910768
[TBL] [Abstract][Full Text] [Related]
50. Secretagogin Mediates the Regulatory Effect of Electroacupuncture on Hypothalamic-Pituitary-Adrenal Axis Dysfunction in Surgical Trauma.
Zhang M; Sun J; Wang Y; Tian Z
Neural Plast; 2021; 2021():8881136. PubMed ID: 33628224
[TBL] [Abstract][Full Text] [Related]
51. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.
Tanoue A; Ito S; Honda K; Oshikawa S; Kitagawa Y; Koshimizu TA; Mori T; Tsujimoto G
J Clin Invest; 2004 Jan; 113(2):302-9. PubMed ID: 14722621
[TBL] [Abstract][Full Text] [Related]
52. The Pituitary-Adrenal Response to Paradoxical Sleep Deprivation Is Similar to a Psychological Stressor, Whereas the Hypothalamic Response Is Unique.
Moraes DA; Machado RB; Koban M; Hoffman GE; Suchecki D
Front Endocrinol (Lausanne); 2022; 13():885909. PubMed ID: 35880052
[TBL] [Abstract][Full Text] [Related]
53. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
Herman JP; Wiegand SJ; Watson SJ
Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
[TBL] [Abstract][Full Text] [Related]
54. Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation.
Volpi S; Rabadan-Diehl C; Aguilera G
Stress; 2004 Jun; 7(2):75-83. PubMed ID: 15512850
[TBL] [Abstract][Full Text] [Related]
55. Arginine vasotocin is the major adrenocorticotropic hormone-releasing factor in the bullfrog Rana catesbeiana.
Okada R; Yamamoto K; Hasunuma I; Asahina J; Kikuyama S
Gen Comp Endocrinol; 2016 Oct; 237():121-130. PubMed ID: 27570059
[TBL] [Abstract][Full Text] [Related]
56. Coupling corticotropin-releasing-hormone and angiotensin converting enzyme 2 dampens stress responsiveness in male mice.
Wang LA; de Kloet AD; Smeltzer MD; Cahill KM; Hiller H; Bruce EB; Pioquinto DJ; Ludin JA; Katovich MJ; Raizada MK; Krause EG
Neuropharmacology; 2018 May; 133():85-93. PubMed ID: 29360543
[TBL] [Abstract][Full Text] [Related]
57. Local Corticotropin-Releasing Factor Signaling in the Hypothalamic Paraventricular Nucleus.
Jiang Z; Rajamanickam S; Justice NJ
J Neurosci; 2018 Feb; 38(8):1874-1890. PubMed ID: 29352046
[TBL] [Abstract][Full Text] [Related]
58. Levels of corticotropin-releasing hormone messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus and proopiomelanocortin mRNA in the anterior pituitary during late gestation in fetal sheep.
Myers DA; Myers TR; Grober MS; Nathanielsz PW
Endocrinology; 1993 May; 132(5):2109-16. PubMed ID: 8386607
[TBL] [Abstract][Full Text] [Related]
59. Central type 2 corticotropin-releasing hormone receptor mediates hypothalamic-pituitary-adrenocortical axis activation in the rat.
Maruyama H; Makino S; Noguchi T; Nishioka T; Hashimoto K
Neuroendocrinology; 2007; 86(1):1-16. PubMed ID: 17551262
[TBL] [Abstract][Full Text] [Related]
60. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes.
Schwartz MW; Strack AM; Dallman MF
Regul Pept; 1997 Oct; 72(2-3):105-12. PubMed ID: 9652969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
